Free Delivery Over £30
Discreet Delivery Always
  • Home
  • Benacort 64 Micrograms Nasal Spray 10ml
  • Benacort 64 Micrograms Nasal Spray 10ml
  • Benacort 64 Micrograms Nasal Spray 10ml
Benacort 64 Micrograms Nasal Spray 10ml _31

Benacort 64 Micrograms Nasal Spray 10ml

Availability: In stock

£6.89 RRP £9.99
add to basket
in stock
Product Notice
To Purchase this product, you will need to answer a medical questionnaire after you select 'add to basket'
Limited to 100 per order
Free Delivery
Over £30
Discreet Delivery
Always
Regulated
Pharmacy
Treatment of seasonal rhinitis should start, if possible, before exposure to the allergens.
 To Buy This Product You Must Answer the Below Questions

Pharmacy medicines are sold at the professional discretion of our pharmacist. Please answer the following questions accurately to allow our pharmacist to check that this product is suitable for the intended user(s). All information provided will be treated confidentially and will only be available to pharmacy staff processing your order.

Important: Our pharmacists only have access to the details you provide in this form. They don't have access to patient information provided online on previous occasions. If your previous responses are shown below, please check that your answers are still correct.

Pharmacy Badge

GPhC Registered Premises: 1103628 * Answer Required

* Answer Required
  • no-option-u.png
  • yes-option.png
  • radio-ticked-img.png
  • radio-un-ticked-img.png
  • radio-un-ticked-img.png
  • radio-un-ticked-img.png
  • radio-ticked-img.png
  • radio-un-ticked-img.png
  • radio-un-ticked-img.png
  • no-option.png
  • yes-option-u.png

  • I will fully read the PIL associated with this product.
  • I will inform my own GP of this purchase if appropriate.
  • All of the information provided is truthful and correct.
  • I agree to the terms and conditions on this website.

  • yes-option.png
  • no-option-u.png

* Required Fields

£6.89 RRP £9.99
Warning Maximum Product Quantity of 100

Benacort 64 Micrograms Nasal Spray 10ml

£6.89
Treatment of seasonal rhinitis should start, if possible, before exposure to the allergens. Try the Benacort Pharmacy Strength Spray for prevention and relief against Hayfever symptoms such as Runny nose, Sneezing & Nasal Congestion
Method of administration

For nasal inhalation.
Disodium edetate

Potassium sorbate (E202)

Glucose anhydrous

Microcrystalline cellulose (E460)

Carboxymethylcellulose sodium (E466)

Polysorbate 80 (E433)

Hydrochloric acid

Purified water
Tabulated list of adverse reactions

Adverse reactions, which have been associated with budesonide, are given below, listed by system organ class and frequency. Frequency is defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1000 to <1/100), rare (≥1/10 000 to <1/1000), very rare (<1/10,000) and not known (cannot be estimated from available data).

Immune system disorders

Uncommon

Immediate and delayed hypersensitivity reactions including urticaria, rash, dermatitis angioedema and pruritus

Rare

Anaphylactic reaction

Endocrine disorders

Rare

Signs and symptoms of systemic corticosteroid effects, including adrenal suppression and growth retardation.

Eye disorders

Rare

Vision, blurred

Not known

Raised intraocular pressure or Glaucoma

Cataract

Respiratory, thoracic and mediastinal disorders

Common

Haemorrhagic secretion and epistaxis

Nasal Irritation (sneezing, stinging and dryness)

Rare

Nasal ulcer

Nasal septum perforation

Dysphonia

Very rare

Ulceration of mucous membrane

Musculoskeletal and connective tissue disorders

Uncommon

Muscle spasm

Injury, poisoning and procedural complications

Rare

Contusion*

* based on mechanistic plausibility and extrapolation from other budesonide/corticosteroid formulations.

In rare cases, signs or symptoms of systemic glucocorticosteroid-side effects such as Cushing's syndrome, Cushingoid features, psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children), may occur with nasal glucocorticosteroids, probably depending on dose, exposure time, concomitant and previous corticosteroid exposure, and individual sensitivity (see section 4.4).

Paediatric population

Growth retardation has been reported in children receiving intranasal steroids. Due to the risk of growth retardation in the paediatric population, growth should be monitored as described in section 4.4.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard.
Treatment should be stopped or the advice of a doctor or pharmacist should be sought if an improvement is not seen within 2 weeks or if symptoms have improved but are not adequately controlled.

This medicine should not be used for more than 3 months continuously without consulting a doctor or pharmacist.

Special care is demanded in treatment of patients transferred from oral steroids to this medicine where disturbances of the hypothalamic-pituitary-adrenal (HPA) axis could be expected.

Special care is needed in patients with fungal and viral infections of the airways and in patients with active or quiescent pulmonary tuberculosis.

Special care is needed where there is an infection in the nasal passages or sinuses, or in the case of recent surgery to the nose, or problems with ulceration in the nose.

Concomitant treatment of seasonal rhinitis may sometimes be necessary to counteract eye symptoms caused by the allergy.

Reduced liver function affects the elimination of corticosteroids, causing lower elimination rate and higher systemic exposure. Be aware of possible systemic side effects.

Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations. Potential systemic effects may include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children).

Visual disturbance

Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.

Paediatric population

The long-term effects of nasal glucocorticosteroids in children are not fully known. Physicians should closely follow the growth of children taking glucocorticosteroids for longer term by any route, and weigh the benefits of the glucocorticosteroid therapy against the possibility of growth suppression.

This medicine should not be used for children or adolescents under 18 years of age.

Treatment with higher than recommended doses may result in clinically significant adrenal suppression. If there is evidence for higher than recommended doses being used, additional systemic corticosteroid cover should be considered during periods of stress or elective surgery.

Co-treatment with CYP3A inhibitors, e.g. itraconazole, ketoconazole, HIV protease inhibitors and cobicistat-containing products is expected to increase the risk of systemic corticosteroid side effects. Therefore, the combination should be avoided unless the benefit outweighs this increased risk, in which case patients should be monitored for systemic corticosteroid side effects. This is of limited clinical importance for short-term (1-2 weeks) treatment with itraconazole or ketoconazole or other potent CYP3A inhibitors, but should be taken into consideration during long-term treatment. A reduction in the dose of budesonide should also be considered.

Shipping Costs

Free UK Delivery on all orders over £30 - Delivery within 3-5 working days

Standard UK Delivery - £2.95 - Delivery within 3-5 working days

 


Please Note: These prices are shown as a guide only. All delivery times are approximate but have been obtained in good faith.

 

Discreet Delivery

All our items are sent completely discreet for your peace of mind.

This means the packaging is plain, there is no mention of what product is inside your package and there is no mention of Chemist 4 U either.

We respect that many of our products are of a sensitive nature - this is why we take every step to keep your purchases private.

 


Returns Information

Customers can read our full returns policy by clicking here

Ask a Pharmacist

Didn't find the answer you were looking for? Submit a private question to be answered by one of our qualified UK pharmacists.

* Name and email address are only captured so you can be emailed a response when your question is answered by a pharmacist. No personally identifiable information is stored or displayed at any time.

See other products tagged as

Hayfever & Allergy